Related Experiment Videos
Flightless I homolog negatively modulates the TLR pathway
Tianyi Wang1, Tsung-Hsien Chuang, Tapani Ronni
1Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|January 21, 2006
Summary
Flightless I homolog (Fliih) acts as a negative regulator in the Toll-like receptor 4 (TLR4)-MyD88 innate immune pathway. Reducing Fliih enhances immune cell activation and cytokine production, revealing a new regulatory mechanism.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Innate immune response knowledge often comes from nonphysiologic models.
- Understanding signaling networks in actual immune cells is crucial.
Purpose of the Study:
- Identify MyD88 signalosome components in murine macrophages.
- Characterize novel MyD88-interacting partners and their regulatory roles.
Main Methods:
- Utilized a dual-tagging proteomic strategy in murine macrophages.
- Stimulated cells with lipid A and analyzed MyD88 interactions.
- Employed small-interfering RNA (siRNA) to reduce Fliih levels.
- Performed immunoprecipitation and two-hybrid assays.
Main Results:
- Identified 16 potential MyD88-interacting partners.
- Verified flightless I homolog (Fliih) interaction with MyD88.
- Demonstrated Fliih as a negative regulator of the TLR4-MyD88 pathway.
- Observed enhanced NF-kappaB activation and cytokine production upon Fliih reduction.
- Showed Fliih directly inhibits TLR4-MyD88 signaling complex formation.
Conclusions:
- Flightless I homolog (Fliih) negatively regulates the TLR4-MyD88 pathway.
- Fliih's interference with signal complex formation is a key regulatory mechanism.
- Suggests a novel basis for TLR pathway regulation by Fliih in innate immunity.